MON-673 Use of Metabolic Syndrome Severity to Assess Treatment with Vitamin-E and Pioglitazone for Non-Alcoholic Steatohepatitis

BACKGROUND: Non-alcoholic steatohepatitis (NASH) represents inflammatory and fibrotic changes in the setting of non-alcoholic fatty liver disease (NAFLD) and can progress to cirrhosis. While clinical management of NASH has proven difficult, the Pioglitazone, Vitamin E or Placebo NASH study (PIVENS)...

Descripción completa

Detalles Bibliográficos
Autores principales: DeBoer, Mark Daniel, Mack, Jasmine A, Gurka, Matthew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208341/
http://dx.doi.org/10.1210/jendso/bvaa046.515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208341/
http://dx.doi.org/10.1210/jendso/bvaa046.515

Ejemplares similares